FDA Inspection
Goetze-Niemer Co IncGoetze-Niemer Co Inc – FDA Inspection, Dec 14, 2015
Record Details
This FDA Inspection record concerns Goetze-Niemer Co Inc, with an inspection on December 14, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Goetze-Niemer Co Inc
- Inspection Date
- December 14, 2015
- Product Type
- Biologics
View Company Profile
ID · 3c8e260b-e1eb-43e6-a782-7b18d2358939
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 952168
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.180(a)Procedures to meet core CTGP
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Goetze-Niemer Co Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2020 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 8, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 19, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Goetze-Niemer Co Inc
- FDA Inspection 1119118 - 2020-02-05
- FDA Inspection 1044414 - 2018-03-08
- FDA Inspection 870748 - 2014-03-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.